2 Billion Doses of the Oxford Coronavirus Vaccine Will Be Developed by Astrazeneca After a $750 Million Deal With Charities Backed by the Bill and Melinda Gates Foundation - GV Wire - Explore. Explain. Expose
Connect with us

Aggregation

2 Billion Doses of the Oxford Coronavirus Vaccine Will Be Developed by Astrazeneca After a $750 Million Deal With Charities Backed by the Bill and Melinda Gates Foundation

Published

on

Share with friends


The vaccine is being produced by AstraZeneca British drug maker, drawing on work by researchers from Oxford University.
It announced Thursday that it had signed agreements with the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi the Vaccine Alliance to boost its supplies.
The company has committed to mass-producing the vaccine before it has been proved effective, an unusual step designed to compress the long timeline of vaccine production.
CEPI and Gavi are both charities supported by the Bill and Melinda Gates Foundation and the World Health Organization, among numerous others. The $750 million agreement with CEPI and Gavi will support manufacturing, procurement and distribution for 300 million of the 2 billion doses.
Read More →